InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by Zannes Timothy P. Director active across 1 company, notably bioAffinity Technologies, Inc.. Aggregated, 4 disclosures have been published. Activity tracked since 17 November 2022. The latest transaction was disclosed on 10 January 2025 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
4 of 4 declarations